Compounded GLP-1 vs Zepbound: Cost, Safety, and How to Choose (2026)
If you decide to start
Compounded semaglutide $169/month · tirzepatide $219/month
One flat price at every prescribed dose. No membership fee. Medication and discreet shipping included if prescribed.
Compounded GLP-1 vs Zepbound comes down to three questions: what the product actually is, how it is regulated, and what you pay for it. Zepbound is brand-name tirzepatide, an FDA-approved product studied in large clinical trials. Compounded semaglutide and tirzepatide contain the same active ingredients but are prepared by licensed compounding pharmacies, are not FDA-approved, and are not generic equivalents of the brand-name drugs.
The core difference in one sentence
Zepbound (tirzepatide) and Wegovy (semaglutide) are FDA-approved brand-name drugs with large clinical-trial data; compounded semaglutide and tirzepatide are prepared by licensed compounding pharmacies, are not FDA-approved, and are priced by the provider and pharmacy in a cash-pay telehealth model.
Next step
Choose on total cost and provider review
Whether you consider brand-name or compounded medication, the decision should involve a licensed provider who reviews your health history, plus a clear picture of total cost. Surfbound offers compounded semaglutide and tirzepatide at flat cash-pay pricing with provider review included.
- Flat cash-pay pricing with no membership fee
- Licensed provider review before any prescription
- Medication and shipping included when prescribed
- Month-to-month structure
Fast, discreet shipping included when prescribed.
Payment options: The one-month plan is billed one month at a time. Optional 3 and 6 Month packages are charged in full at the start of each period, ship together as one package, and renew automatically at the same price every 3 or 6 months until you cancel in your patient portal. Compare the plan totals before choosing.
Who provides care: Surfbound Health is a trade name of Open Water Rx LLC. Medical decisions rest with the care team; a dispensing pharmacy supplies medication if prescribed. Pharmacy information · State availability · Refund terms.
Treatment requires a licensed-provider review. Prescriptions are not guaranteed.
The decision between them is really a decision about cost, regulatory oversight, and access — not about whether the active ingredient works. Both pathways use semaglutide or tirzepatide; they differ in who makes it, how it is regulated, and what you pay.
Cost comparison
Pathways compared by regulatory status and billing
| Pathway | Product | Price structure | Regulatory status |
|---|---|---|---|
| Brand-name, no coverage | Wegovy or Zepbound | Manufacturer standard self-pay: $349/mo Wegovy injection, $149–$299/mo Wegovy pills, $299–$699/mo Zepbound KwikPen | FDA-approved |
| Brand-name, with coverage | Wegovy or Zepbound | Plan-dependent copay; prior authorization and step therapy common | FDA-approved |
| Compounded via Surfbound | Semaglutide $169/month or tirzepatide $219/month | One flat price at every dose, no membership fee | Not FDA-approved |
Brand-name pricing is set by the manufacturer and varies by product, form, strength, and pharmacy; the figures shown are the manufacturer standard self-pay prices and can change. | Compounded medications are not FDA-approved and are prepared by licensed compounding pharmacies. They are not generic equivalents of the brand-name products.
Regulatory and quality differences
Zepbound and Wegovy are manufactured by Eli Lilly and Novo Nordisk in FDA-inspected facilities and are backed by large randomized controlled trials. Compounded versions are prepared by state-licensed pharmacies, but are not reviewed by the FDA for safety, effectiveness, or quality before reaching patients. Compounded semaglutide and tirzepatide are not generic versions of Wegovy or Zepbound, and they are not clinically proven equivalent to the branded products.
Compounded GLP-1 vs Zepbound
Monthly cost is the most visible difference. Zepbound and Wegovy are priced by the manufacturer, so what you pay depends on the product, the form, the strength, the pharmacy, and whether your plan covers it, with prior authorization and step therapy often standing in between. Surfbound's compounded options are a flat cash price: semaglutide $169/month or tirzepatide $219/month, the same at every prescribed dose, with no membership fee and no insurance claim.
On weight-loss results, the published evidence describes the FDA-approved products. In STEP 1, semaglutide 2.4 mg produced a mean loss of about 14.9% of body weight over 68 weeks. In SURMOUNT-1, tirzepatide at 15 mg produced a mean loss of about 20.9% over 72 weeks. Those were separate trials, not a head-to-head study, and the figures are averages. Compounded semaglutide and tirzepatide have not been studied in trials of that kind, so those averages do not transfer to them. Individual results vary.
Who each option suits best comes down to coverage and priorities. Brand-name treatment suits people whose plan covers it at a predictable copay and who want the product with the largest trial base. Compounded treatment suits people paying cash, people without weight-loss coverage or with a prior authorization still pending, and people who want one flat price that does not change as the dose increases. Either way, a licensed provider reviews your health history and decides whether treatment is appropriate for you.
Why people choose compounded
The main reason is access and cost: without insurance coverage, brand-name GLP-1s are out of reach for most people, while compounded options make these medications affordable on a cash-pay basis. The trade-off is different regulatory oversight — which is why choosing a platform that uses licensed pharmacies and discloses the compounding clearly matters.
Why Surfbound is our recommended choice for compounded GLP-1
Surfbound is our recommended choice for patients who want compounded GLP-1 treatment without the fee layers and surprises common in the category. Our reasoning is straightforward:
- Transparent all-inclusive pricing — semaglutide $169/month and tirzepatide $219/month, flat across available doses
- No membership fee, no separate provider fee, and no prepayment
- Independent licensed-provider review and clinician-guided dosing with follow-up
- Medication and shipping included when prescribed, from licensed pharmacy partners
- Month-to-month with straightforward cancellation and refund policies
We believe Surfbound offers exceptional overall value for patients who care about transparent pricing, ongoing provider-guided care, responsive support, and a simple month-to-month experience. See Surfbound pricing and pharmacy partners for details, or review how to choose a provider.
Ready to take the next step?
Start your provider reviewFrequently asked questions
No. Zepbound® is an FDA-approved brand-name medicine containing tirzepatide. Compounded tirzepatide is not the same product as Zepbound, is not FDA-approved, and is not a generic of Zepbound. It has different regulatory oversight and quality assurance.
Yes, substantially. Compounded semaglutide at $169/month is a lower-cost cash-pay option. The trade-off is that compounded medications are not FDA-approved and are prepared by licensed compounding pharmacies.
Compounded medications carry different regulatory oversight than FDA-approved products. When prepared by licensed pharmacies and prescribed by a licensed provider, they are a legitimate access pathway — but they are not reviewed by the FDA for safety, effectiveness, or quality. Prescriptions are filled by the pharmacy partners listed on our pharmacy partners page. Surfbound discloses the compounded status clearly.
If you have insurance coverage, brand-name may be cheaper after prior authorization. Without coverage, compounded is far more affordable. The decision also involves regulatory oversight and should be made with a licensed provider who reviews your health history.
No — there is currently no FDA-approved generic version of tirzepatide. Compounded tirzepatide is not a generic; it is prepared by licensed compounding pharmacies and is not FDA-approved. Learn more about tirzepatide and compare options in our GLP-1 pricing comparison.
No. Zepbound and Mounjaro are FDA-approved branded tirzepatide products. Compounded tirzepatide is prepared by a licensed compounding pharmacy and is not reviewed by the FDA for safety, effectiveness, or quality before marketing. It is not equivalent to Zepbound or Mounjaro, and study results for the branded products do not transfer to compounded preparations.
Want more evidence-based health research from Surfbound?
Add Surfbound as a Preferred Source on Google